<DOC>
	<DOCNO>NCT00220298</DOCNO>
	<brief_summary>This study evaluate preparation testosterone undecanoate condition resemble real-life situation .</brief_summary>
	<brief_title>Assessment Long Term Treatment With Testosterone Undecanoate Males With Hypogonadism</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Hypogonadal men , age 1875 year low serum total testosterone ( TT ) level symptoms androgen deficiency Tumors prostate male mammary gland include suspicion thereof . Past present liver tumor chronic hepatic disease impairment liver function , Severe acne .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>